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Dr Marc Ruel (Ottawa, Ontario, Canada). I wish to
congratulate Dr Elmadhun and her team, in the laboratory ofThe Journal of Thoracic and CarDr Frank Sellke, for an excellent presentation and for providing
me with the report in advance for review.
The findings depicted this morning are important because they
continue to increase our mechanistic understanding of the
angiogenic processes in pathologic cardiovascular states, which
is critical if these therapies are going to hopefully one day work
in the patients for whom they are destined.
In the study, the deleterious effects brought on by the
experimental re-creation of MetS did not exceed the formidable
ability of pediatric swine to normalize myocardial perfusion in
response to ameroid constrictor insertion. However, the core of
the study is what happens ‘‘subclinically.’’ You found that a
number of angiogenic proteins are downregulated by MetS in
this model and that apoptosis is increased. Several of the changes
seemed to occur in the perivascular area of the blood vessels, likely
involving smooth muscle cells.
I have the following questions.
Despite no differences in microsphere myocardial perfusion, is
it possible that the pigs in the MetS group might have been
more ischemic? In other words, are there limitations to micro-
sphere-measured perfusion that would have been highlighted
with imaging or by measuring endothelial-dependent or
even endothelial-independent responses, considering that the
localization of the angiogenic downregulation changes seemed
to occur in the smooth muscle cells. Could new vessels in the
MetS group have been less mature, or leakier, because of
the changes in the smooth muscle cells? Were the left circumflex
territory data compared with a control, non-intervened left
anterior descending or right coronary artery territory?
Dr Elmadhun. Thank you very much, Dr Ruel. To address your
questions: we did perform right and left heart catheterizations at
harvest, and we sent those results to an interventional cardiologist
who was able to quantify the Thrombolysis In Myocardial
Infarction blush score and the Rentrop score. We did not find
any differences between the CTL group and the MetS group;
thus, we do not believe, given that data and the perfusion data,
that the MetS group was more ischemic.
In terms of themicrosphere data limitations, this is the reference
standard to determine perfusion. Other methods can be used to
examine myocardial perfusion.We have previously done magnetic
resonance imaging studies and microvessel reactivity analysis.
However, at our institution, we are unable to do magnetic
resonance imaging studies. However, we did perform microvessel
reactivity studies, and we found increased relaxation in the
MetS group. This finding might have been related to the ‘‘thrifty
genotype’’ of the Ossabaw miniswine, which has allowed them
to survive on Ossabaw Island in the harsh feast and famine
ecology.
Related to vessel leakiness and possible, immature vessels in the
MetS group, this is very likely. However, we only used 1 harvest
point. It would be interesting in future studies to see whether, as
these vessels matured, if any difference was found in the vessel
count at a later point or a difference was found in myocardial
perfusion at a later point. This is an early MetS model. Perhaps
if we had extended this study for 9 months or 1 year or had
performed our study in adult, sexually mature animals, we might
have seen even more differences.diovascular Surgery c Volume 148, Number 3 1055
